BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15735448)

  • 1. Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice.
    Day SL; Leake Date HA; Bannister A; Hankins M; Fisher M
    J Acquir Immune Defic Syndr; 2005 Mar; 38(3):301-4. PubMed ID: 15735448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenofovir disoproxil fumarate-associated hypophosphatemia as determined by fractional excretion of filtered phosphate in HIV-infected patients.
    Cheng CY; Chang SY; Lin MH; Ku SY; Sun NL; Cheng SH
    J Infect Chemother; 2016 Nov; 22(11):744-747. PubMed ID: 27613487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients.
    Gupta SK; Anderson AM; Ebrahimi R; Fralich T; Graham H; Scharen-Guivel V; Flaherty JF; Fortin C; Kalayjian RC; Rachlis A; Wyatt CM
    PLoS One; 2014; 9(3):e92717. PubMed ID: 24651857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.
    Labarga P; Barreiro P; Martin-Carbonero L; Rodriguez-Novoa S; Solera C; Medrano J; Rivas P; Albalater M; Blanco F; Moreno V; Vispo E; Soriano V
    AIDS; 2009 Mar; 23(6):689-96. PubMed ID: 19262355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.
    Cooper RD; Wiebe N; Smith N; Keiser P; Naicker S; Tonelli M
    Clin Infect Dis; 2010 Sep; 51(5):496-505. PubMed ID: 20673002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe.
    Mashingaidze-Mano R; Bwakura-Dangarembizi MF; Maponga CC; Morse GD; Monera-Penduka TG; Mtisi TJ; Mudzviti T; Mujuru HA
    PLoS One; 2020; 15(7):e0235759. PubMed ID: 32634168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.
    Gatanaga H; Tachikawa N; Kikuchi Y; Teruya K; Genka I; Honda M; Tanuma J; Yazaki H; Ueda A; Kimura S; Oka S
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):744-8. PubMed ID: 16910829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.
    Mulenga L; Musonda P; Mwango A; Vinikoor MJ; Davies MA; Mweemba A; Calmy A; Stringer JS; Keiser O; Chi BH; Wandeler G;
    Clin Infect Dis; 2014 May; 58(10):1473-80. PubMed ID: 24585558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
    Bickel M; Khaykin P; Stephan C; Schmidt K; Buettner M; Amann K; Lutz T; Gute P; Haberl A; Geiger H; Brodt HR; Jung O
    HIV Med; 2013 Nov; 14(10):633-8. PubMed ID: 23980564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fanconi syndrome-like tubular acidosis associated with a tenofovir-containing antiretroviral regimen in a human immunodeficiency virus-1-infected Asian woman.
    Kiyasu Y; Koganemaru H; Hitomi S
    J Infect Chemother; 2012 Apr; 18(2):255-7. PubMed ID: 21918819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?
    Havens PL; Kiser JJ; Stephensen CB; Hazra R; Flynn PM; Wilson CM; Rutledge B; Bethel J; Pan CG; Woodhouse LR; Van Loan MD; Liu N; Lujan-Zilbermann J; Baker A; Kapogiannis BG; Gordon CM; Mulligan K;
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5619-28. PubMed ID: 24002093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.
    Cao Y; Han Y; Xie J; Cui Q; Zhang L; Li Y; Li Y; Song X; Zhu T; Li T
    BMC Infect Dis; 2013 Jul; 13():301. PubMed ID: 23815472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in serum mitochondrial creatine kinase levels induced by tenofovir administration.
    Watanabe D; Yoshino M; Yagura H; Hirota K; Yonemoto H; Bando H; Yajima K; Koizumi Y; Otera H; Tominari S; Nishida Y; Kuwahara T; Uehira T; Shirasaka T
    J Infect Chemother; 2012 Oct; 18(5):675-82. PubMed ID: 22350406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study.
    Judd A; Boyd KL; Stöhr W; Dunn D; Butler K; Lyall H; Sharland M; Shingadia D; Riordan A; Gibb DM
    AIDS; 2010 Feb; 24(4):525-34. PubMed ID: 20139752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of proximal renal tubular dysfunction in patients on tenofovir disoproxil fumarate.
    Quinn KJ; Emerson CR; Dinsmore WW; Donnelly CM
    Int J STD AIDS; 2010 Feb; 21(2):150-1. PubMed ID: 20090006
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors.
    Pontrelli G; Cotugno N; Amodio D; Zangari P; Tchidjou HK; Baldassari S; Palma P; Bernardi S
    BMC Infect Dis; 2012 Jan; 12():18. PubMed ID: 22269183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenofovir-induced osteomalacia.
    Wanner DP; Tyndall A; Walker UA
    Clin Exp Rheumatol; 2009; 27(6):1001-3. PubMed ID: 20149322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir-related Fanconi's syndrome and osteomalacia in a teenager with HIV.
    Lucey JM; Hsu P; Ziegler JB
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23843401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians.
    Agbaji OO; Agaba PA; Idoko JA; Taiwo B; Murphy R; Kanki P; Ekong E
    West Afr J Med; 2011; 30(3):164-8. PubMed ID: 22120479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
    Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
    AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.